HealthQuill White Blood Cells
The US drug regulator has put on hold two trials of Gilead Sciences Inc., testing a combination of two of its investigational HIV treatments, after some patients developed lower immune cell counts.
Drugs Health Pharma

Gilead Sciences’ HIV experimental trials put on hold by US drug regulator

HQ Team June 11, 2025: The US drug regulator has put on hold two trials of Gilead Sciences Inc., testing a combination of.

Read More
An investigational therapy from Kite Pharma Inc., a Gilead Sciences company, has reduced tumours in 62% of the patients with a fatal form of brain cancer.
Drugs Health Pharma

Gilead unit’s experimental therapy shrink brain tumours by 62%

HQ Team June 2, 2025: An investigational therapy from Kite Pharma Inc., a Gilead Sciences company, has reduced tumours in 62% of the.

Read More
The US regulatory body has rejected Regeneron Pharmaceuticals, Inc.,’s blood cancer drug as it did not meet the pre-approval standards of the agency.
Drugs Health Pharma

US drug regulator blocks Regeneron’s blood cancer therapy 

The US regulatory body has rejected Regeneron Pharmaceuticals, Inc.,’s blood cancer drug as it did not meet the pre-approval standards of the agency.

Read More
A new vaccine to aid the human body's white cells to fight HIV infection may hold the key to protect people from acquiring the virus, according to a National Institute of Allergic and Infectious Diseases (NIAID) study.
Drugs Health Pharma

New HIV vaccine must aid human white cells to ward off virus: NIAID

HQ Team December 15, 2023: A new vaccine to aid the human body’s white cells to fight HIV infection may hold the key.

Read More